Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rollet-TC is a topical corticosteroid oral paste developed by Droplet Life Science for the treatment of inflammatory and ulcerative lesions of the oral mucosa. It contains 0.1% triamcinolone acetonide, a synthetic corticosteroid that acts as a glucocorticoid receptor agonist to provide anti-inflammatory, anti-pruritic, and vasoconstrictive effects. The formulation utilizes Orabase technology to ensure superior adhesion to the buccal mucosa, allowing the active ingredient to remain in contact with the lesion. It is indicated for conditions such as aphthous ulcers, stomatitis, and other acute or chronic lesions of the oral mucous membranes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Rollet-TC.